◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Senores Pharmaceuticals Limited (SENORES) Financial History

Name: Senores Pharmaceuticals Limited (SENORES) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - General · DATA UPDATED 2026-09-20

Senores Pharmaceuticals Limited (SENORES) operates in the Drug Manufacturers - General industry and is headquartered in Ahmedabad, India with about 368 employees. Its market capitalization is roughly ₹65 billion. In the fiscal year ended 2026-03-31, SENORES reported ₹6.1B in revenue and ₹1.2B in net income.

Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.

Interactive charts & full statements →

SENORES Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	₹6.1B	₹3.8B	₹2.1B	₹353M	—
Gross Profit	₹3.6B	₹1.9B	₹996M	₹226M	—
Operating Income (EBIT)	₹1.4B	₹730M	₹317M	₹109M	—
Net Income	₹1.2B	₹586M	₹314M	₹84M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SENORES Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Total Revenue	₹1.8B	₹1.8B	₹1.6B	₹1.5B	₹1.3B	—	—
Gross Profit	₹1.1B	₹1.1B	₹978M	₹963M	₹712M	—	—
Operating Income (EBIT)	₹438M	₹382M	₹461M	₹414M	₹228M	—	—
Net Income	₹307M	₹316M	₹317M	₹324M	₹197M	—	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SENORES Free Cash Flow History

SENORES Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹16.0B	₹12.3B	₹6.2B	₹1.3B	—
Total Liabilities	₹6.4B	₹4.1B	₹3.9B	₹856M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SENORES viewer.

Other Companies in Drug Manufacturers - General

1093 · CSPC Pharmaceutical Group Limited — HK$102 billion
SANOFICONR · Sanofi Consumer Healthcare India Limited — ₹93 billion
SANOFI · Sanofi India Limited — ₹71 billion
SYMBIOTEC · SYMBIOTEC PHARMALAB LTD — ₹70 billion
4552 · JCR Pharmaceuticals Co., Ltd. — JPY 63 billion
BAYN · Bayer Aktiengesellschaft — €47 billion
SMSPHARMA · SMS Pharmaceuticals Limited — ₹41 billion
SAIPARENT · Sai Parenteral's Limited — ₹23 billion

← SENEB All “S” companies SENS →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.